In a recent discussion of the Ebola outbreak in the eastern Democratic Republic of Congo (DRC), Dr. Peter Salama, Deputy Director-General of Emergency Preparedness and Response for the WHO, properly described the “perfect storm” of a potentially devastating epidemic in the midst of a major security crisis
Quick Read
A comprehensive account of the whistleblowers’ side of a scandal that rocked the most hallowed halls in science. This still-unfolding saga is a cautionary tale about corruption, hype, and power that raises profound questions about how to uphold integrity in scientific research
Quick Read
Will your doctor be happy to see you? People can get a growing number of health-related genetic test results outside the clinical setting. Some direct to consumer (DTC) companies like 23andMe provide a limited number of such results directly to the individual
Quick Read
He wants to give it away for free. A Harvard scientist thinks he’s reached a new milestone: a genetic test that help identify people who are at high risk of heart attacks. Can he convince doctors to use it?
Quick Read
Here Come the Right-To-Try ProfiteersJune 22, 2018 |
The FDA is powerless to stop them. The newly enacted right-to-try law allows drug makers to earn a profit by selling unproven therapies to desperate and dying patients
Quick Read
Charles Longjaw was being held at the Oregon State Hospital after being found insane. Oregon changed its interpretation of the law and he was released, raising questions about how states manage violent offenders with mental illness
Quick Read
Federal regulators approved the first direct-to-consumer test for the BRCA genes, which increase the risk of breast and ovarian cancer, the agency announced on Tuesday
Quick Read
A Better Way to Provide a ‘Right to Try’February 12, 2018 |
First, make sure the FDA stays involved
Quick Read
